Skip to content

Effect of weight loss interventions before assisted reproductive technology on overweight and obesity women:A randomized contrilled trial.

Effect of weight loss interventions before assisted reproductive technology on overweight and obesity women:A randomized contrilled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112593
Enrollment
Unknown
Registered
2025-11-17
Start date
2023-03-07
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility

Interventions

12-hour time-restricted feeding group:beginning 10 weeks before ART, participants followed a Mediterranean-style dietary pattern emphasizing vegetables, high-quality proteins, and whole grains with re
calorie-restricted traditional weight loss group:calorie-restricted traditional weight loss:beginning 10 weeks before ART, participants followed a calorie-restricted diet within1200-1500kcal per day
control group:Only standardised advice and education identical to that provided to the intervention group, with no other interventions.

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. aged 20-38 years; 2.40kg/m^2>=BMI>=24kg/m^2; 3.with strong desire to lose weight and be pregnant; 4.AMH>=0.5ng/ml;

Exclusion criteria

Exclusion criteria: 1. Long-term night work or insomnia; 2. Severe metabolic diseases (hyperthyroidism, hypothyroidism, Cushing's syndrome, pituitary amenorrhea, etc.); 3.Gastrointestinal, cardiovascular diseases; 4.Smoking, alcoholism; 5.Azoospermia; 6.Endometriosis, uterine synechiae, myomas affecting the endometrium, recurrent biochemical pregnancies, repeated implantation failure, and recurrent spontaneous abortion (three or more consecutive miscarriages before 28 weeks of gestation). 7.The endometrial thickness during the ovulatory phase is less than 6 mm. 8.Donor egg recipient; 9.Severe immunological disorders (such as systemic lupus erythematosus, antiphospholipid syndrome, etc.);

Design outcomes

Primary

MeasureTime frame
cumulative live birth rate;

Secondary

MeasureTime frame
clinical pregnancy rate;miscarriage rate;LH?FSH?E2?P,insulin,glucose,TG,HDL,LDL,auxin;weight,body fat;

Countries

China

Contacts

Public Contacttanjichun

Shengjing Hospital of China Medical University

tanjc@sj-hospital.org+86 18940251868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026